s / Placenta 35 (2014) A1eA112 A6 PL4.3. THE EFFECT OF MATERNAL DIABETES ON FETO-PLACENTAL ENDOTHELIAL CELLS Ursula Hiden , Silvija Cvitic , Francisca Diaz , Evelyn JantscherKrenn , Gernot Desoye a Department of Obstetrics and Gynecology, Medical Univeristy of Graz, Graz, Austria; b Institute of Cell Biology, Histology and Embryology, Medical University of Graz, Graz, Austria Gestational diabetes mellitus (GDM) is one of the most frequent pregnancy pathologies. As other types of diabetes and resulting from the obesity epidemic, GDM is a growing problemworldwide. Even by women under good glycaemic control, the maternal diabetic environment causes metabolic derangements in the fetus. Thus, the fetal environment is characterized by hyperglycaemia, hyperinsulinemia, metabolicallyinduced hypoxia and altered levels of growth factors which affect placental and fetal development. Histological studies revealed hypervascularisation and reduced endothelial expression of cell junction molecules in the placenta. Furthermore, placental vessels show altered response to vaso-relaxing agents. These findings indicate changes in placental endothelial functions as a consequence of the diabetic environment in utero. The human placenta is a rich source of primary feto-placental endothelial cells and thus gives a great opportunity to investigate endothelial changes occurring in pregnancy pathologies such as GDM. These primary fetoplacental endothelial cells are well characterized and maintain their phenotype in vitro. Using these human primary feto-placental endothelial cells, we revealed that the intrauterine diabetic environment indeed causes sustainable functional changes in placental endothelial cells. These changes are represented by altered angiogenesis, proliferation and gene expression. We speculate that the endothelial cell phenotype in GDM contributes to altered placental function and may even reflect changes in the fetuses of diabetic mothers. PL5.1. UTERO-PLACENTAL VASCULARIZATION DURING THE FIRST TRIMESTER: WHAT ARE THE NON-INVASIVE IMAGING TOOLS IN 2014? Olivier Morel , Anne-Claire Chabot-Lecoanet , Jie Duan , Estelle Perdiolle-Galet a,b Regional Maternity of University, Nancy, France; b IADI Inserm U947, Nancy, France Introduction: The physiopathology of utero-placental (UP) vascularization development is still partially unknown. Major progresses have been achieved, such as the description of the myometrial vascular shunt. Major endpoints, however, such as the perfusion timing of intervillous space by maternal blood, remain unclear. This review aimed to evaluate available non-invasive imaging techniques of UP vascularization during the first trimester. Methods: literature review from Medline. Results: Until recently, 2D Doppler examination was the reference. However, its poor predictive values make it unusable in clinical practice. 3D Doppler angiography (3DPD), more sensitive to slow flow, now allows to quantify flows directly into the UP unit. The predictive value of this test for the prediction of preeclampsia (PE) and intrauterine growth restriction (IUGR) seems high. However, this technique has two major drawbacks: its dependence on machine settings and the lack of information as to the direction of flow, which makes it impossible to disentangle maternal and fetal flow. Performance could be improved by contrast agents. New MRI sequences (BOLD) seem to allow an early diagnosis of IUGR in animal models. Spatial resolution and motion artifacts are the main limitations of this technique. Conclusion: Over the last decade, two new techniques for UP vascularization study have emerged to complement the classical 2D Doppler: the 3DPD and new angio-MRI sequences that do not require use of contrast. They provide the ability to quantify perfusion signal directly within the UP unit, and may permit in the near future major progresses both for the understanding of the physiology of the UP visualization and for the prediction of PE and IUGR. PL5.2. PLACENTAL STRUCTURE AND FUNCTION IN FETAL GROWTH RESTRICTION AND STILLBIRTH C.P. Sibley , V. Abrahams , S. Girard , L. Higgins , E.D. Johnstone , R.L. Jones , A.E.P. Heazell a Maternal and Fetal Health Research Centre, University of Manchester, Manchester, UK; Yale School of Medicine, Yale,
Read full abstract